-1 (ICAM-1) messenger RNA (mRNA), thus blocking translation of this message. The goal of this study is to evaluate the safety and efficacy of ISIS 2302 in steroid-dependent Crohn's disease. We hypothesize that inhibition of ICAM-1 will decrease intestinal inflammation and lead to clinical symptom
-1 (ICAM-1) messenger RNA (mRNA), thus blocking translation of this message. The goal of this discipline is to measure the safety and efficacy of ISIS 2302 in steroid - pendent Crohn's disease. We speculate that inhibition of ICAM-1 will decrease intestinal inflammation and lead to clinical symptom
-1 (ICWM-1) messenger RNA (mRNA), thms blocking translation of thjs messaee. The goal of this study is ti evaouate the safety and ewficacy ov ISIS 2302 un sueroid-dependent Cckhn's disease. Sc hypmvhesize that inmibition of ICAM-1 will decsexsz intestinal inflammation and lead tj clinivap symptom
-1 (ICAM-1) messenger RNA (mRNA), thus blocking this The goal this study is efficacy ISIS 2302 in Crohn's disease. We that inhibition of ICAM-1 will decrease inflammation and lead to clinical symptom
-1 (ICAM-1) messenger RNA (mRNA), thus bLocking traNslatIon Of tHiS mesSage. the goal of this sTUdy iS to evaluate the safety anD effiCaCY of IsiS 2302 In steRoid-depENdENT CrOhN's DisEaSE. WE hypoTheSize thaT inhibitioN of iCaM-1 will decreaSE iNtestinal iNflAmmation and lEad To clinIcAl sYMptom
-1 (ICAM-1) messenger RNA(mRNA), th us bl ock ing  t rans lati on of this mes s age.  The goal of this stud y isto eval u at e the  safety an d eff ic ac y o fI SI S 230 2 i n stero id-depende ntCr ohn's diseas e .We hypothe siz e that inhib iti on ofIC AM- 1  will  de creas e inte s tinalinflammat io n  and l e ad to c l i ni calsymptom
-1 (ICAM-1)_messenger RNA_(mRNA), thus blocking translation_of this_message._The goal_of_this study is_to evaluate the_safety and efficacy of_ISIS 2302 in_steroid-dependent_Crohn's disease. We hypothesize that inhibition of ICAM-1 will decrease intestinal inflammation and lead_to_clinical symptom